Loading...
Market
Which country will first approve human trials for the 'Supermodel granny' drug by the end of 2025?
2
Resolution / Starting Odds
United States • 25%
United Kingdom • 25%
China • 25%
Other • 25%
Official announcements from regulatory bodies or government agencies
Story
'Supermodel Granny' Drug Extends Animal Lifespan by Blocking Interleukin-11, Nature Study Finds
Jul 17, 2024, 04:51 PM
A new drug, referred to as the 'Supermodel granny' drug, has shown promising results in extending the lifespan of animals. The drug works by blocking inflammation, specifically targeting interleukin-11, according to recent research published in Nature. This discovery, which involves interleukin-11 knockout or inhibition, could pave the way for the development of anti-aging drugs, offering a potential breakthrough in lifespan and healthspan expansion. However, questions remain about the short lifespan of control mice used in the study.
View original story
Similar markets
USA • 25%
UK • 25%
Germany • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
UK • 14%
USA • 14%
Germany • 14%
France • 14%
Japan • 14%
Australia • 14%
Other • 14%
Russia • 25%
Europe (excluding Russia) • 25%
North America • 25%
Asia (excluding Russia) • 25%
United States • 25%
United Kingdom • 25%
Canada • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
United States • 25%
European Union • 25%
United Kingdom • 25%
Other • 25%
United States • 25%
European Union • 25%
China • 25%
Other • 25%
Japan • 25%
United States • 25%
European Union • 25%
Other • 25%
United States • 25%
United Kingdom • 25%
Germany • 25%
Other • 25%
Yes • 50%
No • 50%
United States • 25%
European Union • 25%
China • 25%
Other • 25%